Clinical Characteristics of Control Group with Infiltrating Transitional Bladder Carcinoma
| Patient no. | Age (y) | PSA (ng/mL) | Free-to-total PSA | DRE | TRUS | Prostate volume (cm3) | TNM (bladder) | Tumor grade |
|---|---|---|---|---|---|---|---|---|
| 1 | 65 | 2.1 | 18 | − | − | 30 | T1 N0 | 2–3 |
| 2 | 70 | 2.8 | 24 | − | − | 40 | T3b N0 | 3 |
| 3 | 65 | 2.0 | 20 | − | − | 30 | T1 N0 | 3 |
| 4 | 64 | 1.3 | 30 | − | − | 45 | T1 N0 | 3 |
| 5 | 71 | 1.6 | 25 | − | − | 40 | T3b N0 | 3 |